CONMED Corporation (CNMD)
Automate Your Wheel Strategy on CNMD
With Tiblio's Option Bot, you can configure your own wheel strategy including CNMD - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CNMD
- Rev/Share 42.5092
- Book/Share 31.5641
- PB 1.8277
- Debt/Equity 0.9126
- CurrentRatio 2.2568
- ROIC 0.0695
- MktCap 1784922831.0
- FreeCF/Share 5.3128
- PFCF 10.8471
- PE 15.0469
- Debt/Assets 0.3883
- DivYield 0.0139
- ROE 0.1265
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 4
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | CNMD | Stifel | Buy | Hold | -- | $55 | April 28, 2025 |
| Downgrade | CNMD | JP Morgan | Overweight | Neutral | $85 | $70 | Feb. 6, 2025 |
News
CONMED Corporation Appoints LaVerne Council as Chair of the Board of Directors
Published: May 21, 2025 by: Business Wire
Sentiment: Neutral
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that LaVerne Council has been appointed to succeed Martha Goldberg Aronson as the new Independent Chair of its Board of Directors, effective May 21, 2025. “LaVerne's extensive experience as a global operations and information technology executive have been invaluable to CONMED, and I know that her experience will continue to serve the Board and the Company well in her new role as Chair of the Board,” said Pat Beyer, P.
Read More
Here's Why Conmed (CNMD) is a Strong Value Stock
Published: May 19, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Why Conmed (CNMD) is a Top Value Stock for the Long-Term
Published: May 02, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
CNMD Stock Up On Q1 Earnings & Sales Beat, Raised 2025 Outlook
Published: May 01, 2025 by: Zacks Investment Research
Sentiment: Positive
CNMD reports solid first-quarter results, driven by improving sales across both segments.
Read More
CONMED Corporation (CNMD) Q1 2025 Earnings Call Transcript
Published: April 30, 2025 by: Seeking Alpha
Sentiment: Neutral
CONMED Corporation (NYSE:CNMD ) Q1 2025 Earnings Conference Call April 30, 2025 4:30 PM ET Company Participants Pat Beyer - Chief Executive Officer and President Todd Garner - Executive Vice President and Chief Financial Officer Conference Call Participants Matt O'Brien - Piper Sandler Robbie Marcus - JPMorgan Rick Wise - Stifel Young Li - Jefferies Travis Steed - Bank of America Mike Matson - Needham Operator Good day, and thank you for standing by. Welcome to CONMED's First Quarter Fiscal 2025 Earnings Conference Call.
Read More
4 Stocks to Watch as Dental Supplies Recovers Amid Tariff Headwind
Published: April 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These are CAH, MMSI, XRAY and CNMD.
Read More
About CONMED Corporation (CNMD)
- IPO Date 1987-07-23
- Website https://www.conmed.com
- Industry Medical - Devices
- CEO Mr. Patrick J. Beyer
- Employees 3900